Manus Neurodynamica: Funding, Investors & Team (Oct 2026)
Manus Neurodynamica is a triage device to support early diagnostics in Parkinson's disease.
Manus Neurodynamica has raised $4.8M across 2 funding rounds on record, the most recent an undisclosed round of $3.2M announced in May 2023.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Manus Neurodynamica Company Profile and Key Stats
Latest funding round on record: May 2023.
Manus Neurodynamica Funding Rounds
Manus Neurodynamica raised $1.6M in an undisclosed round announced in Jan 2021.
2.3 years later, an undisclosed round of $3.2M was announced in May 2023.
Manus Neurodynamica Founders and Leadership Team
Contact details for the Manus Neurodynamica team: 1 of 1 has an email address on file.
Start 14-day free trial →Manus Neurodynamica Funding Compared to Other Biotechnology Startups
Manus Neurodynamica's latest round of $3.2M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Manus Neurodynamica in Biotechnology and Edinburgh
Companies Similar to Manus Neurodynamica
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
Manus Neurodynamica Funding FAQs
What does Manus Neurodynamica do?
Manus Neurodynamica is a triage device to support early diagnostics in Parkinson's disease.
How much funding has Manus Neurodynamica raised?
Manus Neurodynamica has raised $4.8M across 2 rounds on record. The most recent is an undisclosed round of $3.2M announced in May 2023.
When did Manus Neurodynamica last raise funding?
Manus Neurodynamica's most recent funding round on record is an undisclosed round of $3.2M, announced in May 2023.
Who is the CEO of Manus Neurodynamica?
Rutger Zietsma is listed as CEO at Manus Neurodynamica.
Where is Manus Neurodynamica headquartered?
Manus Neurodynamica is based in Edinburgh, United Kingdom.
How many employees does Manus Neurodynamica have?
Manus Neurodynamica is in the 1-10 employee band.
How does Manus Neurodynamica's funding compare to other Biotechnology startups?
Manus Neurodynamica's latest round of $3.2M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Manus Neurodynamica Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Manus Neurodynamica is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.